Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of Mycobacterium tuberculosis.

Saved in:

Bibliographic Details
Title:	Immune Responses Following BCG Immunization of Infants in Uganda and United Kingdom Are Similar for Purified Protein Derivative but Differ for Secretory Proteins of Mycobacterium tuberculosis.
Authors:	Mawa PA; Immunomodulation and Vaccines Programme, Medical Research Council-Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.; Department of Immunology, Uganda Virus Research Institute, Entebbe, Uganda.; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Hasso-Agopsowicz M; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Lubyayi L; Immunomodulation and Vaccines Programme, Medical Research Council-Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.; Department of Epidemiology and Biostatistics, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa., Nabakooza G; Immunomodulation and Vaccines Programme, Medical Research Council-Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda., Nakibuule M; Immunomodulation and Vaccines Programme, Medical Research Council-Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda., Blitz R; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Dun L; Fetal Medicine Unit, Gynaecology and Obstetrics Department, North Middlesex University Hospital National Health Service Trust, London, United Kingdom., Govind A; Fetal Medicine Unit, Gynaecology and Obstetrics Department, North Middlesex University Hospital National Health Service Trust, London, United Kingdom., Kaleebu P; Immunomodulation and Vaccines Programme, Medical Research Council-Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.; Department of Immunology, Uganda Virus Research Institute, Entebbe, Uganda., Webb EL; Medical Research Council Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Elliott AM; Immunomodulation and Vaccines Programme, Medical Research Council-Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom., Dockrell HM; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Cose S; Immunomodulation and Vaccines Programme, Medical Research Council-Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom., Smith SG; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Source:	Frontiers in immunology [Front Immunol] 2021 Mar 19; Vol. 12, pp. 637114. Date of Electronic Publication: 2021 Mar 19 (Print Publication: 2021).
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-3224
DOI:	10.3389/fimmu.2021.637114